rivastigmine has been researched along with Neuroblastoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Borges, F; Brunetti, L; Cardoso, SM; Chavarria, D; Chaves, S; Guedes, B; Madrid, Y; Piemontese, L; Santos, MA; Vicente-Zurdo, D | 1 |
Hamidi, M; Hosseini, MJ; Kaboli, Z; Manjili, HK; Rostamizadeh, K; Sadighian, S | 1 |
Ceruti, M; Giammona, G; Licciardi, M; Pitarresi, G; Rocco, F; Scialabba, C | 1 |
Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
4 other study(ies) available for rivastigmine and Neuroblastoma
Article | Year |
---|---|
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Chelating Agents; Cholinesterase Inhibitors; Ferric Compounds; Humans; Monoamine Oxidase; Neuroblastoma; Neurodegenerative Diseases; Rivastigmine | 2023 |
Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease.
Topics: Alzheimer Disease; Animals; Drug Carriers; HEK293 Cells; Humans; Neuroblastoma; Polyesters; Polyethylene Glycols; Polymers; Quercetin; Rats; Rivastigmine | 2023 |
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Micelles; Neuroblastoma; Neurons; Neuroprotective Agents; Particle Size; Peptides; Phenylcarbamates; Rivastigmine; Spectrometry, Fluorescence | 2012 |
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |